A novel glutamic acid to aspartic acid mutation near the end of the 2B rod domain in the keratin 1 chain in epidermolytic hyperkeratosis

被引:21
作者
Yang, JM
Nam, K
Kim, HC
Lee, JH
Park, JK
Wu, K
Lee, ES
Steinert, PM
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Dermatol,Kangnam Ku, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Samsung Biomed Res Inst, Clin Res Ctr, Sch Med, Seoul, South Korea
[3] Chungnam Natl Univ, Coll Med, Dept Dermatol, Taejon, South Korea
[4] NIAMSD, Skin Biol Lab, NIH, Bethesda, MD USA
关键词
epidermolytic hyperkeratosis; glutamic acid; keratin;
D O I
10.1038/sj.jid.5600439
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report a mutation in a mild case of epidermolytic hyperkeratosis that results in a glutamic acid to aspartic acid substitution in a novel location, codon 477 or position 106 of the 2B rod domain of the keratin 1 chain. This residue has been conserved in all intermediate filament chains and lies near the beginning of the highly conserved helix termination sequence and just prior to the predicted molecular overlap region. Keratin filaments assembled in vitro from chains bearing this substitution are abnormal, indicating that the glutamic acid residue is critically involved in ionic interactions in intermediate levels of filament structure.
引用
收藏
页码:376 / 379
页数:4
相关论文
共 16 条
[1]   A highly conserved lysine residue on the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornified cell envelope through isopeptide crosslinking by transglutaminases [J].
Candi, E ;
Tarcsa, E ;
Digiovanna, JJ ;
Compton, JG ;
Elias, PM ;
Marekov, LN ;
Steinert, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (05) :2067-2072
[2]   BIOCHEMICAL, STRUCTURAL, AND TRANSGLUTAMINASE SUBSTRATE PROPERTIES OF HUMAN LORICRIN, THE MAJOR EPIDERMAL CORNIFIED CELL-ENVELOPE PROTEIN [J].
CANDI, E ;
MELINO, G ;
MEI, G ;
TARCSA, E ;
CHUNG, SI ;
MAREKOV, LN ;
STEINERT, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26382-26390
[3]   THE GENETIC-BASIS OF EPIDERMOLYTIC HYPERKERATOSIS - A DISORDER OF DIFFERENTIATION-SPECIFIC EPIDERMAL KERATIN GENES [J].
CHENG, J ;
SYDER, AJ ;
YU, QC ;
LETAI, A ;
PALLER, AS ;
FUCHS, E .
CELL, 1992, 70 (05) :811-819
[4]  
CHIPEV CC, 1994, AM J HUM GENET, V54, P179
[5]   A LEUCINE-]PROLINE MUTATION IN THE H1 SUBDOMAIN OF KERATIN-1 CAUSES EPIDERMOLYTIC HYPERKERATOSIS [J].
CHIPEV, CC ;
KORGE, BP ;
MARKOVA, N ;
BALE, SJ ;
DIGIOVANNA, JJ ;
COMPTON, JG ;
STEINERT, PM .
CELL, 1992, 70 (05) :821-828
[6]  
DIGIOVANNA JJ, 1994, J INVEST DERMATOL, V102, P390
[7]   CLINICAL HETEROGENEITY IN EPIDERMOLYTIC HYPERKERATOSIS [J].
DIGIOVANNA, JJ ;
BALE, SJ .
ARCHIVES OF DERMATOLOGY, 1994, 130 (08) :1026-1035
[8]  
DIGIOVANNA JJ, 1998, TXB MOL MED 8, P707
[9]   INTERMEDIATE FILAMENTS - STRUCTURE, DYNAMICS, FUNCTION, AND DISEASE [J].
FUCHS, E ;
WEBER, K .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :345-382
[10]   SELECTIVE INVOLVEMENT OF KERATIN-K1 AND KERATIN-K10 IN THE CYTOSKELETAL ABNORMALITY OF EPIDERMOLYTIC HYPERKERATOSIS (BULLOUS CONGENITAL ICHTHYOSIFORM ERYTHRODERMA) [J].
ISHIDAYAMAMOTO, A ;
MCGRATH, JA ;
JUDGE, MR ;
LEIGH, IM ;
LANE, EB ;
EADY, RAJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (01) :19-26